These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7017552)

  • 1. [Therapy of Bartter syndrome with indomethacin].
    Ploier R; Tulzer W; Fink M; Bohrn E
    Padiatr Padol; 1981; 16(1):81-92. PubMed ID: 7017552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical findings, pathogenesis and treatment of Bartter's syndrome (author's transl)].
    Ploier R; Tulzer W
    Wien Med Wochenschr; 1981; 131(11):287-93. PubMed ID: 7020264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bartter's syndrome: Recurrence in the course of a treatment inhibiting prostaglandin synthesis].
    Favre L; Glasson P; Flory ED; Dray F; Vallotton MB
    Schweiz Med Wochenschr; 1979 Feb; 109(5):142-7. PubMed ID: 441720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bartter's syndrome: the long term effects of indomethacin on growth (author's transl)].
    Floret D; David M; Roux A; Hage GN; Teyssier G
    Nouv Presse Med; 1979 Jan; 8(1):17-21. PubMed ID: 122007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of prostaglandins in Bartter's syndrome.
    Winterborn MH; Hewitt GJ; Mitchell MD
    Int J Pediatr Nephrol; 1984 Mar; 5(1):31-8. PubMed ID: 6370882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bartter's syndrome: 10 cases in childhood. Results of long-term indomethacin therapy.
    Dillon MJ; Shah V; Mitchell MD
    Q J Med; 1979 Jul; 48(191):429-46. PubMed ID: 120550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of indomethacin in a patient with Bartter's syndrome: evidence against a primary role of prostaglandin in this disorder.
    Etzioni A; Chaimovitz C; Levi Y; Benderli A; Better OS
    Pediatr Res; 1980 Dec; 14(12):1395-7. PubMed ID: 7010289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value and limitations of indomethacin in the treatment of Bartter's syndrome].
    Dequiedt P; Lefebvre J; Raviart B; Vanhille P; Lepoutre E; Lelièvre G; Tacquet A
    J Urol Nephrol (Paris); 1977 Sep; 83(9):688-93. PubMed ID: 926230
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bartter's syndrome. Failure of aspirin and success of indomethacin].
    Jáuregui WO; Di Fonzo P; Marchissio ML; Roehr E; Hauger-Klevene JH
    Medicina (B Aires); 1979; 39(4):447-56. PubMed ID: 397398
    [No Abstract]   [Full Text] [Related]  

  • 10. Reversal of altered vascular responsiveness in Bartter's syndrome by indomethacin treatment.
    Shimoyama R
    J Clin Endocrinol Metab; 1980 Oct; 51(4):908-11. PubMed ID: 6999001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indomethacin for Bartter's syndrome.
    Zancan L; Zacchello F; Mantero F
    Lancet; 1976 Dec; 2(7999):1354. PubMed ID: 63823
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chronization by indomethacin of the circadian rhythm of blood renin and aldosterone in a case of Bartter's syndrome].
    Cugini P; Lucia P; Murano G; Letizia C; Panichi G; Adone G; Vetere AM; Magnanelli S
    Minerva Urol Nefrol; 1985; 37(1):23-7. PubMed ID: 3901335
    [No Abstract]   [Full Text] [Related]  

  • 13. [Variations in renin and aldosterone activity in a typical case of Barter syndrome. Influence of anti-aldosterones and sodium intake].
    Zech P; Pozet N; Sassard J; Leitienne P; Blanc N; Colon S; Berthoux F; Touraine JL; Traeger J
    J Urol Nephrol (Paris); 1974 Sep; 80(9):760-5. PubMed ID: 4463254
    [No Abstract]   [Full Text] [Related]  

  • 14. [Bartter syndrome and pseudo-Bartter syndrome--a case report].
    Gläser V; Hallebach V; Hans S
    Z Urol Nephrol; 1986 Jan; 79(1):19-27. PubMed ID: 3515804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indomethacin in Bartter's syndrome: does the syndrome represent a state of hyperprostaglandinism?
    Donker AJ; de Jong PE; van Eps LW; Brentjens JR; Bakker K; Doorenbos H
    Nephron; 1977; 19(4):200-13. PubMed ID: 917167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bartter's syndrome. Current prospects of nosographic classification and new therapeutic possibilities].
    Cordone G; Fasce L; Gianfranceschi P; Delucchi M; Iester A; Torcia R
    Minerva Pediatr; 1978 Jul; 30(13):1097-104. PubMed ID: 672851
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of indomethacin on the vascular abnormalities of Bartter's syndrome.
    Richards CJ; Mark AL; Van Orden DE; Kaloyanides GJ
    Circulation; 1978 Sep; 58(3 Pt 1):544-9. PubMed ID: 679446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Bartter's syndrome with indomethacin.
    Garin EH; Fennell RS; Iravani A; Richard GA
    Am J Dis Child; 1980 Mar; 134(3):258-61. PubMed ID: 6767392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin synthetase inhibitors in Bartter's syndrome. Effect on immunoreactive prostaglandin E excretion.
    Bowden RE; Gill JR; Radfar N; Taylor AA; Keiser HR
    JAMA; 1978 Jan; 239(2):117-21. PubMed ID: 412983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome: therapeutic use of the cyclooxygenase-2 inhibitor nimesulide.
    Nüsing RM; Reinalter SC; Peters M; Kömhoff M; Seyberth HW
    Clin Pharmacol Ther; 2001 Oct; 70(4):384-90. PubMed ID: 11673754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.